Symplast Announces Growth Financing from Level Structured Capital to Accelerate Commercial Expansion
Summary
Symplast announced growth financing from Level Structured Capital to accelerate its commercial and go-to-market expansion. The investment will fund scaling the sales organization, deepen Symplast's presence in The Aesthetic Society, and amplify its Beautiful Business and You Deserve the Best campaigns while also supporting AI-powered product innovation. Symplast is a mobile-first, cloud-based, AI-powered practice management platform for aesthetic plastic surgery and was named 2026 Best in KLAS for Ambulatory Plastic Surgery Solutions. Level Structured Capital, a software-focused investor within Level Equity, backed the deal after customer references and will support the company as it scales.
Funding
Amount
None
Total raised
Date
May 13, 2026
Announcement date
Investors
Level Equity
Lead investors
Company
symplast.com
Funded company
Classifications
industries
HealthTech
applications
Data Management
AskAI Classifications
Labels
Healthcare Software
Medical Practice Management Software
Electronic Health Records (EHR)
Linked Companies
Symplast
$1M to $5M